Neogen Chemicals Promoter Pledges 13,19,083 Equity Shares for Group Company Funding

1 min read     Updated on 01 Apr 2026, 10:40 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dr. Harin Haridas Kanani, promoter of Neogen Chemicals Limited, has pledged 13,19,083 equity shares (5% of paid-up capital) on March 30, 2026, to facilitate borrowing by promoter group entity Cadamba Solutions Private Limited. The shares were pledged in favor of Axis Trustee Services Limited, with Dr. Kanani maintaining his overall 12.65% shareholding in the company while creating this encumbrance for group financing purposes.

powered bylight_fuzz_icon
36565803

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals promoter Dr. Harin Haridas Kanani has disclosed the creation of a pledge on 13,19,083 equity shares of the company on March 30, 2026. The pledged shares constitute 5% of the company's paid-up capital and were encumbered to facilitate borrowing and fund raising activities by Cadamba Solutions Private Limited, a promoter group member.

Pledge Transaction Details

The disclosure filed under Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 reveals the following transaction specifics:

Parameter: Details
Pledged Shares: 13,19,083 equity shares
Percentage of Capital: 5%
Date of Creation: March 30, 2026
Beneficiary Entity: Cadamba Solutions Private Limited
Trustee: Axis Trustee Services Limited
Type of Encumbrance: Pledge

Promoter Holdings Overview

Dr. Harin Haridas Kanani's shareholding position before and after the pledge creation shows his significant stake in the company:

Holding Details: Pre-Pledge Post-Pledge
Total Shares Held: 33,38,250 33,38,250
Percentage Holding: 12.65% 12.65%
Previously Encumbered: 0 shares (0%) -
Currently Pledged: - 13,19,083 shares (5%)

Promoter Group Structure

The disclosure also provides a comprehensive view of the promoter group's shareholding pattern, with various family trusts and individual promoters holding stakes in the company. The Haridas Kanani Family Trust holds the largest stake at 20% with 52,76,500 shares, followed by Dr. Harin Haridas Kanani's individual holding of 12.65%.

Regulatory Compliance

The pledge creation has been duly reported to both BSE Limited and National Stock Exchange of India Limited as per regulatory requirements. The company trades on BSE with scrip code 542665 and on NSE with the symbol NEOGEN. The disclosure ensures transparency regarding changes in promoter shareholding encumbrances as mandated by securities regulations.

Purpose and Implications

The pledged shares will serve as security for borrowing arrangements by Cadamba Solutions Private Limited, indicating the promoter group's strategic financial planning. This transaction represents a standard corporate finance mechanism where promoter holdings are leveraged to support group company funding requirements while maintaining operational control of the listed entity.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+9.07%+19.49%-0.15%-11.07%-8.32%+53.51%

What specific business expansion or investment plans does Cadamba Solutions Private Limited have that necessitated this borrowing arrangement?

How might this 5% pledge impact Neogen Chemicals' stock price and investor confidence in the near term?

Could this pledge creation signal potential future dilution of promoter holdings or lead to additional encumbrances?

Neogen Chemicals EGM Resolution Passes with Overwhelming 99.99% Shareholder Approval

2 min read     Updated on 31 Mar 2026, 02:08 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Neogen Chemicals successfully concluded its extraordinary general meeting on March 29, 2026, with shareholders providing overwhelming support of 99.99% approval for the preferential issuance of equity shares to promoter group members. The meeting, conducted through video conferencing, saw participation from 88 shareholders and recorded over 2.04 crore votes through remote e-voting and e-voting during the meeting, representing 77.39% of outstanding shares.

powered bylight_fuzz_icon
36327201

*this image is generated using AI for illustrative purposes only.

Neogen chemicals conducted an extraordinary general meeting on March 29, 2026, to deliberate on the preferential issuance of equity shares to its promoter group members. The meeting concluded with overwhelming shareholder support, as the resolution received 99.99% approval from voting members.

Meeting Structure and Participation

The EGM commenced at 11:30 a.m. IST and concluded efficiently at 11:56 a.m. IST under the chairmanship of Mr. Anurag Surana, Chairman and Non-Executive Director. Company Secretary Unnati Kanani welcomed shareholders, directors, and auditors who participated through the electronic platform provided by MUFG Intime India Private Limited (formerly Link Intime India Private Limited).

Meeting Details: Information
Date: March 29, 2026
Start Time: 11:30 a.m. IST
End Time: 11:56 a.m. IST
Format: Video Conferencing/Audio-Visual Means
Chairman: Mr. Anurag Surana
Total Shareholders on Record: 55,158
Shareholders Attended via VC: 88 (15 Promoter Group, 73 Public)

Voting Results and Overwhelming Approval

The resolution for preferential equity share issuance to promoter group members secured exceptional shareholder support. CS Devendra V. Deshpande from DVD & Associates served as the appointed scrutinizer for the voting process.

Voting Summary: Details
Total Valid Votes Cast: 2,04,17,139
Votes in Favor: 2,04,17,119
Votes Against: 20
Approval Percentage: 99.9999%
Record Date: March 20, 2026

Category-wise Voting Breakdown

The voting pattern demonstrated strong support across all shareholder categories:

Shareholder Category: Votes Polled Votes in Favor Approval Rate
Promoter and Promoter Group: 1,35,12,677 1,35,12,677 100%
Public-Institutions: 62,66,630 62,66,630 100%
Public-Non Institutions: 6,37,832 6,37,812 99.9969%

E-voting Process and Timeline

The company facilitated comprehensive voting arrangements through multiple channels. Remote e-voting was available from Thursday, March 26, 2026, at 9:00 a.m. IST through Saturday, March 28, 2026, at 5:00 p.m. IST. Additionally, e-voting during the EGM was provided for members who had not participated in remote voting.

E-voting Statistics: Numbers
Remote E-voting: 1,93,15,448 votes
E-voting During EGM: 11,01,691 votes
Total E-votes: 2,04,17,139 votes
Voting Percentage of Outstanding Shares: 77.39%

Regulatory Compliance and Documentation

On March 30, 2026, the company submitted the consolidated voting results and scrutinizer's report to BSE Limited and National Stock Exchange of India Limited under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting proceedings were conducted in full compliance with regulatory requirements, with the notice dated March 7, 2026, and corrigendum dated March 17, 2026, distributed to all registered shareholders.

Resolution Details and Business Agenda

The meeting focused on a single special resolution regarding the issuance of equity shares on preferential basis to promoter group members. The resolution was deemed passed on March 29, 2026, with the requisite majority secured through the voting process.

Resolution Specifications: Details
Resolution Type: Special Business
Subject: Preferential Equity Share Issuance
Beneficiary: Promoter Group Members
Status: Passed with Requisite Majority
Scrutinizer: CS Devendra V. Deshpande (FCS 6099)

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+9.07%+19.49%-0.15%-11.07%-8.32%+53.51%

What specific growth initiatives or expansion plans will Neogen Chemicals fund with the capital raised from this preferential share issuance?

How might this increase in promoter shareholding affect Neogen's corporate governance structure and minority shareholder influence?

Will this preferential issuance impact Neogen's eligibility for institutional investment or inclusion in key market indices?

More News on Neogen Chemicals

1 Year Returns:-8.32%